Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises the sellers in the sale of Larodan AB to ABITEC Corporation
Mandate

Vinge advises the sellers in the sale of Larodan AB to ABITEC Corporation

July 08, 2020 M&A Employment and Benefits

Vinge advises the owners of Larodan AB in the sale of the company to ABITEC Corporation, a subsidiary in the listed corporate group Associated British Foods, plc (“ABF”).

Larodan AB develops, manufactures and sells a broad range of high purity lipids for research and analytical purposes to customers across the world. The transaction is of strategic importance for ABITEC and ABF, as it expands the group’s product portfolio and provides ABITEC with an R&D site in Europe.

The Vinge team consisted primarily of Jesper Ottergren, Victoria Johnsson Grossman and Charlotte Akej (M&A) and Daniel Melander Björner (Employment Law).

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

 Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

 Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026